i " 容忍 " 推出患者视频系列,强调1型糖尿病的抗争及其治疗研究。 iTolerance launches patient video series highlighting Type 1 diabetes struggles and its research toward a cure.

iTolerance， Inc. 推出了一个患者旅程视频系列，展示了受 1 型糖尿病影响的个人和家庭的真实经历，首先是公司咨询小组的家长和新成员 Sandra Cohen Kalter，分享她儿子的诊断和日常挑战。 iTolerance, Inc. has launched a Patient Journey video series showcasing real experiences of individuals and families affected by Type 1 Diabetes, beginning with Sandra Cohen Kalter, a parent and new member of the company’s advisory group, sharing her son’s diagnosis and daily challenges. 该系列旨在提高人们对该疾病持续负担和需要更好治疗的认识。 The series aims to raise awareness about the disease’s ongoing burden and the need for better treatments. i " 容忍 " 正在开发SA-FasL微凝胶平台,以便能够进行没有终身免疫抑制的胰岛素移植,并有可能提供治疗,同时还在推进肝衰竭和器官移植治疗。 iTolerance is developing its SA-FasL microgel platform to enable pancreatic islet transplants without lifelong immunosuppression, potentially offering a cure, and is also advancing therapies for liver failure and organ transplants. 该公司网站提供视频,计划播放更多片段。 Videos are available on the company’s website, with more episodes planned. 该公司指出,其前瞻性声明涉及风险和不确定性。 The company notes that its forward-looking statements involve risks and uncertainties.